PARIS
France
4
2024-10-03
4
2024-11-19
These are the the leading inventors for applications assigned to BIOPROJET Pharma:
BIOPROJET Pharma based in PARIS, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Polymorph form of pitolisant hydrochloride
#2 | 2023-06-01 ✅ Patent 12,582,648 granted on 2026-03-24METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS USING DOPAMINE D3 PARTIAL AGONISTS
#3 | 2020-03-26 ✅ Patent 11,179,329 granted on 2021-11-23Therapeutical use of H3-ligands
#4 | 2020-01-23 ✅ Patent 11,078,183 granted on 2021-08-03Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same
Also check out BIOPROJET Pharma's (Paris, France) applicant profile with 8 patent applications submitted.
154020 ⎘